Effect of delaying prophylaxis against CMV in D+/R− solid organ transplant recipients in the development of CMV-specific cellular immunity and occurrence of late CMV disease-Reference-Cited by-同舟云学术

Effect of delaying prophylaxis against CMV in D+/R− solid organ transplant recipients in the development of CMV-specific cellular immunity and occurrence of late CMV disease

Published:2015-11 Issue:5 Volume:71 Page:561-570
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

San-Juan R.,Navarro D.,García-Reyne A.,Montejo M.,Muñoz P.,Carratala J.,Len O.,Fortun J.,Muñoz-Cobo B.,Gimenez E.,Eworo A.,Sabe N.,Meije Y.,Martín-Davila P.,Andres A.,Delgado J.,Jimenez C.,Amat P.,Fernández-Ruiz M.,López-Medrano F.,Lumbreras C.,Aguado J.M.

Funder

Department of Health, Spain

Agency for Health Technology Assessment and Research

Ministerio de Economía y Competitividad, Instituto de Salud Carlos III

Spanish Network for the Research in Infectious Diseases

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference18 articles.

1. A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients;Sagedal;Transplantation,2000

2. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients;Paya;Am J Transpl,2004